Skip to main content

Table 5 Cost-benefit

From: A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma

Outpatient-basis or home Inpatient-basis
At home malignant tumor Basic admission fee 472,900 yen
   Administration fee 25,000 yen Local infusion technical fee (addition to minute infusion) 46,200 yen
Portable infuser pump  
   using fee 15,000 yen Diet 63,600 yen
Medication Medication
   CDDP 20,000 yen    CDDP 20,000 yen
   5-FU 15,000 yen    5-FU 15,000 yen
Tumor marker 5,000 yen Tumor marker 5,000 yen
Other laboratory test 8,400 yen Other laboratory test 8,400 yen
Imaging diagnosis 15,000 yen Imaging diagnosis 15,000 yen
(antiemeric drug 16,000 yen) (antiemeric drug 16,000 yen)
Total 103,600 (119,600) yen Total 646,300 (662,300) yen
  1. (One month treatment covered by Japanese National Health Insurance, A U.S. dollar is approximately equivalent to 104 Japanese yen)